Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
First Look: Insurers, Auto Rules, AI and Fed Jitters
07:38am, Thursday, 04'th Dec 2025
Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health
Merck & Co., Inc. $MRK Shares Sold by Groupe la Francaise
04:43am, Thursday, 04'th Dec 2025
Groupe la Francaise lessened its position in shares of Merck and Co., Inc. (NYSE: MRK) by 34.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commissi
Merck & Co., Inc. (NYSE:MRK) Trading 1.3% Higher After Analyst Upgrade
01:28am, Thursday, 04'th Dec 2025
Shares of Merck and Co., Inc. (NYSE: MRK - Get Free Report) rose 1.3% during mid-day trading on Wednesday after The Goldman Sachs Group raised their price target on the stock from $92.00 to $120.00. T
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
Merck & Co., Inc. (MRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
06:03pm, Wednesday, 03'rd Dec 2025
Merck & Co., Inc. (MRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Merck & Co., Inc. (MRK) Presents at Evercore 8th Annual Healthcare Conference Transcript
04:13am, Wednesday, 03'rd Dec 2025
Merck & Co., Inc. (MRK) Presents at Evercore 8th Annual Healthcare Conference Transcript
17 dividend-stock bargains from a value manager with a stellar track record
12:11pm, Tuesday, 02'nd Dec 2025
John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”
Why Merck (MRK) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 02'nd Dec 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One
08:51am, Tuesday, 02'nd Dec 2025
The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.
Beacon Pointe Advisors LLC Grows Position in Merck & Co., Inc. $MRK
05:18am, Tuesday, 02'nd Dec 2025
Beacon Pointe Advisors LLC increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 2.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The
Merck & Co., Inc. $MRK Stock Position Increased by Brandes Investment Partners LP
04:36am, Tuesday, 02'nd Dec 2025
Brandes Investment Partners LP boosted its position in shares of Merck and Co., Inc. (NYSE: MRK) by 5.3% in the undefined quarter, according to its most recent disclosure with the Securities and Excha
Trump Administration Locks In Zero Tariffs On UK Pharmaceuticals As NHS To Pay More For US Drugs
04:02am, Tuesday, 02'nd Dec 2025
The UK and the U.S. have reached a landmark agreement to eliminate tariffs on British pharmaceutical products being exported to America.
Top 10 High-Yield Dividend Stocks For December 2025
02:20pm, Monday, 01'st Dec 2025
The November 2025 high-yield dividend watchlist delivered a 2.94% gain in last month, outperforming SPY and closely trailing VYM. This watchlist blends quality and value to identify high-yield stocks
Here's Why Merck (MRK) is a Strong Momentum Stock
10:51am, Monday, 01'st Dec 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025
06:45am, Monday, 01'st Dec 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025.
